Madrigal Pharmaceuticals (MDGL) Inventory (2024 - 2026)

Madrigal Pharmaceuticals (MDGL) has 3 years of Inventory data on file, last reported at $112.1 million in Q1 2026.

• On a quarterly basis, Inventory rose 102.87% year-over-year to $112.1 million in Q1 2026; TTM through Mar 2026 was $112.1 million, a 102.87% increase from a year earlier, with the FY2025 full-year figure at $74.8 million, up 119.68% from the prior year.
• Inventory for Q1 2026 stood at $112.1 million, up from $74.8 million in the prior quarter.
• Over the last five years, Inventory for MDGL reached as high as $112.1 million in Q1 2026 and fell as low as $854000.0 in Q1 2024.
• Historically, Inventory has averaged $47.3 million across 3 years, with a median of $55.2 million in 2025.
• Across the five-year window, Inventory soared 6368.5% in 2025 and soared 102.87% in 2026, its largest moves.
• Year by year, Inventory stood at $34.1 million in 2024, then soared by 119.68% to $74.8 million in 2025, then jumped by 49.74% to $112.1 million in 2026.
• Per Business Quant data, the three most recent Inventory figures were $112.1 million in Q1 2026, $74.8 million in Q4 2025, and $69.3 million in Q3 2025.